Beximco Pharmaceuticals Limited

AIM:BXP Stock Report

Market Cap: UK£240.0m

Beximco Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BXP?
Owner TypeNumber of SharesOwnership Percentage
Private Companies14,345,7573.22%
Institutions17,290,8593.88%
Individual Insiders18,138,9834.07%
General Public396,336,49088.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 11.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.22%
New Dacca Industries Ltd.
14,345,757UK£7.7m0%no data
3.21%
Norges Bank Investment Management
14,315,902UK£7.7m0%no data
2.04%
Salman Rahman
9,080,095UK£4.9m0%no data
2.03%
Ahmed Sohail Rahman
9,058,888UK£4.9m0%no data
0.32%
Legal & General Investment Management Limited
1,407,037UK£757.0k0%no data
0.21%
Tundra Fonder AB
935,000UK£503.0k0%0.05%
0.083%
eQ Asset Management Ltd.
369,467UK£198.8k0%0.02%
0.054%
Parametric Portfolio Associates LLC
243,003UK£130.7k-9.33%no data
0.0046%
Eurizon Capital S.A.
20,450UK£11.0k0%no data